NCT07243301

Brief Summary

This randomized, double-blind controlled study aims to evaluate the effectiveness of thread implantation acupuncture at EX-B2 L1 in reducing postoperative pain and improving quality of life in patients undergoing laparoscopic living donor nephrectomy. Thirty-four participants will be randomly assigned to receive either thread implantation acupuncture with polydioxanone (PDO) thread at EX-B2 L1 plus standard postoperative therapy or sham thread implantation acupuncture without thread insertion plus the same standard therapy. Pain intensity will be assessed using the Visual Analogue Scale (VAS) and quality of life with the Short-Form 36 (SF-36). The study seeks to determine whether thread implantation acupuncture provides additional analgesic and quality-of-life benefits beyond standard postoperative care.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
32

participants targeted

Target at below P25 for not_applicable postoperative-pain

Timeline
Completed

Started Feb 2025

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 10, 2025

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 10, 2025

Completed
7 days until next milestone

First Submitted

Initial submission to the registry

November 17, 2025

Completed
4 days until next milestone

First Posted

Study publicly available on registry

November 21, 2025

Completed
19 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 10, 2025

Completed
Last Updated

January 8, 2026

Status Verified

January 1, 2026

Enrollment Period

9 months

First QC Date

November 17, 2025

Last Update Submit

January 7, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in Pain Intensity (Visual Analogue Scale)

    Visual Analogue Scale (0-100 mm) measured at Day 0 (baseline), Day 1, 2, 3, and 14 post-surgery.

    From baseline to postoperative Day 14

Secondary Outcomes (3)

  • Change in Quality of Life (Short Form-36)

    Baseline and Day 14.

  • Analgesic Use

    Day 0-14.

  • Adverse Events Adverse Events Adverse Events

    Up to Day 14

Study Arms (2)

Intervention Group

EXPERIMENTAL

Thread implantation acupuncture

Device: Thread implantation acupuncture

Control Group

SHAM COMPARATOR

Sham thread implantation acupuncture

Device: Sham thread implantation acupuncture

Interventions

Thread implantation acupuncture performed bilaterally at EX-B2 (L1) using polydioxanone (PDO) thread (26G × 38 mm) inserted subcutaneously to a depth of approximately 1-1.5 cm. The procedure is conducted once under aseptic conditions before surgery, combined with standard postoperative analgesic therapy.

Intervention Group

Sham thread embedding acupuncture performed bilaterally at EX-B2 (L1) using a blunt needle without thread insertion, mimicking the procedure but without embedding material. Participants also receive standard postoperative therapy.

Control Group

Eligibility Criteria

Age21 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Living kidney donors scheduled to undergo laparoscopic living donor nephrectomy.
  • Aged 21-60 years.
  • Willing to participate and able to sign written informed consent

You may not qualify if:

  • Hypersensitivity to thread-embedding acupuncture (TEA).
  • History of keloid formation or tendency to develop keloids.
  • Skin disorders at or near the planned TEA insertion sites.
  • Neurological abnormalities or lower-limb deficits on physical examination.
  • History of spinal surgery or scheduled for spinal surgery within the next 7 months.
  • Scoliosis based on clinical examination.
  • Other causes of low back pain, such as inflammatory spondylitis, spinal infection, or tumor.
  • Planning to become pregnant within 7 months after LNDH.
  • Body Mass Index (BMI) \< 18 kg/m².
  • Uncontrolled diabetes mellitus.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Universitas Indonesia

Jakarta Pusat, Dki Jakarta, 10430, Indonesia

Location

MeSH Terms

Conditions

Pain, Postoperative

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Study Officials

  • KEPK FKUI-RSCM

    The Health Research Ethics Commitee - Faculty of Medicine Universitas Indonesia and Dr. Cipto Mangunkusumo National Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
Blinding will be applied to participants and outcome assessors. Group allocation will not be disclosed to them to minimize assessment bias.
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: The intervention group will receive thread implantation acupuncture, while the control group will receive sham thread implantation acupuncture.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

November 17, 2025

First Posted

November 21, 2025

Study Start

February 10, 2025

Primary Completion

November 10, 2025

Study Completion

December 10, 2025

Last Updated

January 8, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

Locations